Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer, Translational Oncology

Manuel Hidalgo

MD, PhD

🏢Weill Cornell Medicine, NewYork-Presbyterian Hospital🌐USA

Professor of Medicine

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Manuel Hidalgo is a world-leading expert in pancreatic cancer whose translational research has advanced systemic treatment strategies for this lethal malignancy. He conducted seminal studies on FOLFIRINOX and nab-paclitaxel combinations, establishing them as standards of care for pancreatic ductal adenocarcinoma. His patient-derived pancreatic tumor organoid models have enabled personalized drug testing to guide treatment decisions. He leads major international pancreatic cancer consortia and clinical trial programs.

Share:

🧪Research Fields 研究领域

pancreatic cancer treatment
FOLFIRINOX
gemcitabine combinations
pancreatic cancer clinical trials
stromal targeting

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Manuel Hidalgo 的研究动态

Follow Manuel Hidalgo's research updates

留下邮箱,当我们发布与 Manuel Hidalgo(Weill Cornell Medicine, NewYork-Presbyterian Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment